Neuropsychiatric Disorders in Hospitalized Patients Undergoing Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma

被引：0
作者：
Lawal, Odunayo [1 ]
Lupak, Oleksandra [2 ]
Udo, Itoro [3 ]
Emole, Josephine [4 ]
机构：
[1] Univ Arizona, Clin & Translat Sci Program, Tucson, AZ USA
[2] Med Univ South Carolina, Hematol Oncol, Charleston, SC 29425 USA
[3] Western Univ, Dept Psychiat, London, ON, Canada
[4] Henry Ford Hosp, Stem Cell Transplantat & Cellular Therapy, Detroit, MI 48202 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2021年 / 21卷
关键词：
CT; CAR-T therapy; neuropsychiatric disorders; multiple myeloma;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT-423
引用
收藏
页码：S454 / S454
页数：1
相关论文
共 50 条
[31]   Communication About Chimeric Antigen Receptor T-Cell (CAR-T) Therapy [J].
Dhawale, Tejaswini ;
Johnson, P. Connor ;
Boateng, Kofi ;
Barata, Anna ;
Traeger, Lara ;
Nelson, Ashley M. ;
Lavoie, Mitchell W. ;
Holmbeck, Katherine ;
Choe, Joanna ;
Nabily, Anisa ;
Tripathi, Astha ;
Amonoo, Hermioni L. ;
Frigault, Matt ;
El-Jawahri, Areej .
TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (04) :402.e1-402.e12
[32]   Chimeric Antigen Receptor (CAR) therapy for multiple myeloma [J].
Atanackovic, Djordje ;
Radhakrishnan, Sabarinath V. ;
Bhardwaj, Neelam ;
Luetkens, Tim .
BRITISH JOURNAL OF HAEMATOLOGY, 2016, 172 (05) :685-698
[33]   Chimeric Antigen Receptor T Cells in Multiple Myeloma [J].
Shah, Parth ;
Sperling, Adam S. .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 37 (06) :1089-1105
[34]   B-cell maturation antigen chimeric antigen receptor-T therapy alleviated heart failure in patients with multiple myeloma [J].
Wang, Yunhong ;
Zhang, Ke ;
Suo, Xiaohui ;
Meng, Ning ;
Gu, Yuanrui ;
Qin, Yilang ;
Tu, Yanxia ;
Zhang, Xiaohui ;
Sun, Guofeng ;
Ji, Jiaojiao ;
Wu, Weichun ;
Cai, Yuqi ;
Yang, Kai ;
Ouyang, Chenxi ;
Qi, Junyuan .
ESC HEART FAILURE, 2024, 11 (01) :574-580
[35]   Advancing Multiple Myeloma Immunotherapy: A Review of Chimeric Antigen Receptor T-Cell and Bispecific T-Cell Engagers Cell Therapies in Revolutionizing Treatment [J].
Navab, Rahul ;
Futela, Pragyat ;
Kumari, Verkha ;
Valecha, Jayesh ;
Gupta, Ramansh Bandhu ;
Jain, Rohit .
IRANIAN JOURNAL OF MEDICAL SCIENCES, 2025, 50 (01) :1-10
[36]   BCMA-targeting chimeric antigen receptor T cell therapy for relapsed and/or refractory multiple myeloma [J].
Fang, Jiamin ;
Zhou, Fuling .
ANNALS OF HEMATOLOGY, 2024, 103 (04) :1069-1083
[37]   Chimeric antigen receptor T-cell therapy in hematopoietic and nonhematopoietic malignancies [J].
Ahmad, Faizan .
BIOMEDICAL AND BIOTECHNOLOGY RESEARCH JOURNAL, 2020, 4 (03) :179-185
[38]   Chimeric Antigen Receptor T-Cell Therapy: The Light of Day for Osteosarcoma [J].
Lin, Zili ;
Wu, Ziyi ;
Luo, Wei .
CANCERS, 2021, 13 (17)
[39]   Impact of Prior Selinexor Exposure on Outcomes of Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Exploratory Analysis [J].
Costa, Bruno Almeida ;
Dima, Danai ;
Mark, Tomer ;
Sadek, Norah Layla ;
Ijioma, Stephen ;
Ray, David ;
Goel, Utkarsh ;
Dranitsaris, George ;
Sheng, Tianxiang ;
Moshier, Erin ;
Mouhieddine, Tarek H. ;
Khouri, Jack ;
Rossi, Adriana .
JOURNAL OF CLINICAL MEDICINE, 2025, 14 (04)
[40]   Comprehensive meta-analysis of anti-BCMA chimeric antigen receptor T-cell therapy in relapsed or refractory multiple myeloma [J].
Zhang, Lina ;
Shen, Xuxing ;
Yu, Wenjun ;
Li, Jing ;
Zhang, Jue ;
Zhang, Run ;
Li, Jianyong ;
Chen, Lijuan .
ANNALS OF MEDICINE, 2021, 53 (01) :1547-1559
12345